Robert Dasilva, MD
Sports Medicine · Columbia, SCNPI 1770583817
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (45.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Medacta USA, Inc. at 31.6% of the total. Reporting peaked in 2019 at $4,487 and has fallen 89.4% since, to $475 in 2025.
Across 92 payments — averaging $79.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medacta USA, Inc.$2K
- Zimmer Biomet$2K
- Arthrex$1K
- Peerless Surgical Inc.$1K
- Zyla Life Sciences, Inc.$154
- Stryker$125
- plus $278 from 10 others
What the payments were for
- Travel & lodging$2,66336%
- Food & beverage$3,30445%
- Education$1,33418%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medacta USA, Inc. | 11 | $2,309 |
| Zimmer Biomet | 29 | $2,034 |
| Arthrex | 3 | $1,358 |
| Peerless Surgical Inc. | 8 | $1,045 |
| Zyla Life Sciences, Inc. | 26 | $154 |
| Stryker | 2 | $125 |
| Bioventus LLC | 3 | $70 |
| Smith+Nephew | 2 | $59 |
| Myoscience Inc. | 1 | $29 |
| Innovation Technologies Inc | 1 | $24 |
| Convatec Inc. | 1 | $21 |
| Medtronic | 1 | $16 |
| Amgen | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Eagle Pharmaceuticals, Inc. | 1 | $15 |
| Sanara Medtech Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GMK SPHERE$1,149
- GMK REVISION$774
- ROSA-Knee$632
- ROSA$374
- mymobility Platform$148
- MECTA$137
- AMISTEM$125
How this compares
$7,302 in reported general payments places this provider in the 70th percentile of 158 sports medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 552 | $17,117 |
| EliquisApixaban | 38 | $10,312 |
| Naloxone Hcl | 26 | $1,594 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 127 | $856 |
| Celecoxib | 39 | $738 |
| Ondansetron OdtOndansetron | 58 | $557 |
| Diclofenac Sodium | 35 | $427 |
| Oxycodone Hcl | 73 | $402 |
| Mupirocin | 69 | $402 |
| Meloxicam | 82 | $293 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 45 | $273 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 22 | $140 |
| Tramadol Hcl | 38 | $122 |
| Cyclobenzaprine Hcl | 13 | $114 |
| Promethazine Hcl | 25 | $80 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Columbia
- Silas HolmesColumbia$2.2M
- Jeffrey GuyColumbia$120K
- James O LearyColumbia$39K
- Christopher MazoueColumbia$20K
- Gregory PennyColumbia$17K
- Robert BrowningColumbia$12K
- Andrew McGownColumbia$8K
- Candler MathewsColumbia$4K
- Stephan PillGreenville$688K
- Steven MartinSeneca$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.